The preservation effect of coronary collateral circulation on left ventricular function in chronic total occlusion

Yuxiang Dai1, Shufu Chang1, Shen Wang2

  • 1Department of Cardiology, Fudan University Affiliated Zhongshan Hospital, Shanghai, China.

Insights

Good coronary collateral circulation preserves left ventricular ejection fraction (LVEF) in patients with coronary chronic total occlusion (CTO). Vascular endothelial growth factor-A (VEGF-A) may promote collateral formation, aiding heart function.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Molecular Medicine

Background:

  • Coronary chronic total occlusion (CTO) often presents with collateral circulation, which can mitigate ischemia and preserve ventricular function.
  • Understanding the role of these collaterals in maintaining left ventricular (LV) function is crucial for patient outcomes.

Purpose of the Study:

  • To investigate the impact of coronary collateral circulation on left ventricular (LV) function in patients with coronary CTO.
  • To explore the underlying mechanisms involved in the development of coronary collateral circulation.

Main Methods:

  • 102 coronary CTO patients were categorized by left ventricular ejection fraction (LVEF) into preserved (≥50%) and decreased (<50%) groups.
  • Clinical, angiographic, and laboratory data were analyzed, including serum VEGF-A levels and VEGF-A gene mRNA expression.
  • Multivariate logistic regression identified predictors of LVEF preservation.

Main Results:

  • Rentrop grades 2-3 and coexisting collateral pathways independently predicted LVEF preservation in coronary CTO patients.
  • Patients with better collateralization (Rentrop grades 2-3) exhibited smaller LV dimensions and higher LVEFs.
  • Higher serum VEGF-A and mRNA expression were observed in patients with better collateralization.

Conclusions:

  • Coronary collateral circulation is significantly associated with preserved LVEF in coronary CTO.
  • VEGF-A is implicated as a potential promoter of coronary collateral circulation formation.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
289
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
779
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
241